WorksheetsOCULAR PHARMACOLOGY AAA
Total questions: 150
Worksheet time: 13hrs 30mins
where does cyclopentolate belong
cholinomimetic agent
adrenomimetic agent
parasympatholytic agent
sympatholytic agent
MOA of 2% cyclopentolate
inhibit Ach by acting directly on receptor site
inhibit AchE allowing released Ach to act on receptor
enhance the release of Ach at presynaptic neuron
mimic the effect of Ach at receptor site
what are the ocular effects of 2% cyclopentolate during refraction
produce mydriasis with cycloplegia
produce mydriasis w/o cycloplegia
produce miosis with accommodation
produce miosis w/o accommodation
color cap of ophthalmic cyclopentolate
red
green
brown
blue
classify cyclopentolate according to its use
diagnostic agent
curative agent
palliative agent
protective agent
reason why the child suddenly manifests behavioral changes
child is happy because she can now see clearly with her new eyeglasses
child is sad because she does not like the eyeglasses
CNS side effect at 2% cyclopentolate
ANS side effect at 2% cyclopentolate
safest concentration of the cyclopentolate to prevent behavioral changes in the child
0.5%
5%
0.05%
10%
safest diagnostic ophthalmic mydriatic medication for a 10 year old
0.5% atropine
0.5% tropicamide
2.5% phenylephrine
4% cocaine
which among the ff. mydriatic and cycloplegic agent is the strongest
0.5% atropine
0.5% tropicamide
2.5% phenylephrine
2% cyclopentolate
which among the ff. mydriatic and cycloplegic agent is the weakest
0.5% atropine
0.5% tropicamide
2.5% phenylephrine
2% cyclopentolate
mydriatic and cycloplegic agent has rapid onset of action which can dilate the pupils in 15-20 minutes
0.5% atropine
0.5% tropicamide
2.5% phenylephrine
2% cyclopentolate
where does 2.5% phenylephrine belong
cholinomimetic agent
adrenomimetic agent
parasympatholytic agent
sympatholytic agent
classify 2.5% phenylephrine according to its selectivity
selective a1 agonist
non selective adrenergic agonist
selective a1 blocker
non selective adrenergic blocker
ocular effects of 2.5% phenylephrine during refraction
produce mydriasis with cycloplegia
produce mydriasis w/o cycloplegia
produce miosis with accommodation
produce miosis w/o accommodation
which of the ff. is NOT the ocular structures interacted upon by 2.5% phenylephrine
ciliary muscles
radial muscles of iris
conjunctival arteries
mueller's muscles of eyelids
the ff. are ocular effect of using 2.5% phenylephrine except
accommodation
mydriasis
conjunctival arterey blanching
lid retraction
color cap of ophthalmic 2.5% phenylephrine
red
green
brown
blue
classify 2.5% phenylephrine according to its use
diagnostic agent
curative agent
palliative agent
protective agent
after doing refraction for distance, px was advice to read at RSTC for near vision. why is it that the px could be able to read with corrected eyeglasses even though pupils are dilated
because px has cataract and become more myopic
because phenylephrine only dilates the pupils without affecting the ciliary muscles
because the pupils of the px constrict to increase the DOF
because px has better lighting as compared at home
the ff. are contra indication of 2.5% - 10% phenylephrine except
hypertension
bronchial asthma
myocardial infarction
congestive heart failure
why is it that px manifest chest and nape pain using 10% phenylephrine
px failed to take antihypertensive agent
phenylephrine elevates the blood pressure
phenylephrine dilate cerebral arteries that causes HA
dilated pupils cause HA on the px
as an optometrist, what will you do to the px after suffering chest and nape pain using 20% phenylephrine
give him a potent analgesic to relieved the pain
give him sublingual Nifedipine to lower the BP
advice the px to take his medication and go the nearby medical clinic for further evaluation
continue doing the refraction, it will pass away
what is the reversing agent to the mydriatic effect of 2.5% phenylephrine
0.5% dapiprazole
0.5% tropicamide
4% cocaine
0.5% proparacaine
ocular side effect of 2.5% phenylephrine
melanin like (adenochrome) deposits at cornea
optic neuritis and optic nerve atrophy
xanthopsia
retinopathy
what is the type of glaucoma if the px's IOP was elevated after using 2.5% phenylephrine
primary angle closure glaucoma
primary open angle glaucoma
secondary angle closure glaucoma
secondary open angle glaucoma
which of the ff. is NOT the ocular effect of 2.5% phenylephrine
contraction of dilator pupillae
conjunctival blanching acting as ocular decongestant
contraction of mueller muscles of eyelids
ciliary injection
condition using 2.5% phenylephrine which relieves incomplete ptosis
adie's pupil
argyll robertson pupil
marcus gunn pupil
horner's syndrome
propriety name of 2.5% phenylephrine if the medication will be bought at drug store
mydriacyl
miostat
mydfrin
atroptal
if the ophthalmologists instil one drop every 5 minutes for 3 doses at 9:00am, what time will the pupil start to dilate
9:15am
1:00pm
9:30am
9:00pm
at what time will the pupil start to react on light after instillation of 2.5% phenylephrine
9:15am
1:00pm
9:30am
9:00pm
reason why 3 dose every 5 minutes are usually done to attain maximum pupillary dilatation
first 2 doses bind with melanin pigments while last dose binds with dilator pupillae
first 2 doses will egress to puncta lacrimalis while the last dose pass the cornea barriers
to prolonged the contact time of the medication
that is what the ophthalmologists are usually doing
reversing agent to the mydriatic effect of phenylephrine
0.5% timolol
0.5% apraclonidine
0.5% proparacaine
0.5% dapiprazole
color cap of the reversing agent of 2.5% phenylephrine
red
green
brown
blue
diagnostic dye in strip used by the licensed optometrist
fluorescein dye
lissamine green dye
rose bengal dye
indocyanine green dye
the ff. diagnostic dyes act by staining devitalized cells except
fluorescein dye
lissamine green dye
rose bengal dye
indocyanine green dye
which dye for angiography will shows the not only the retinal vessels but also the choroidal vessels
fluorescein dye
lissamine green dye
rose bengal dye`
indocyanine green dye
the ff. are the indications of using fluorescein dye in strip except
fitting of hard cl
TBUT
angiography
jones test 1
indication of using fluorescein dye in TBUT
determine the patency of lacrimal passage
determine if there is mucin deficiency that causes dry eye syndrome
determine the pattern of retinal vessels for any obstruction or hemorrhages
measures intraocular pressure
indication of using fluorescein dye during angiography
determine the patency of lacrimal passage
determine if there is mucin deficiency that causes dry eye syndrome
determine the pattern of retinal vessels for any obstruction or hemorrhages
measures intraocular pressure
indication of using fluorescein dye in Fluorescein dye test 1
determine the patency of lacrimal passage
determine if there is mucin deficiency that causes dry eye syndrome
determine the pattern of retinal vessels for any obstruction or hemorrhages
measures intraocular pressure
indication of using fluorescein dye using applanation tonometer
determine the patency of lacrimal passage
determine if there is mucin deficiency that causes dry eye syndrome
determine the pattern of retinal vessels for any obstruction or hemorrhages
measures intraocular pressure
what is the importance of doing seidel test using fluorescein dye
determine aqueous leakage post intraocular operations
determine if there is epithelial breaks wherein the dye is located at anterior aqueous chamber
shows corneal dendritic pattern on cornea
shows fishnet mosaic pattern of pre corneal tear film
what is the importance of doing pseudoflare using fluorescein dye
determine aqueous leakage post intraocular operations
determine if there is epithelial breaks wherein the dye is located at anterior aqueous chamber
shows corneal dendritic pattern on cornea
shows fishnet mosaic pattern of pre corneal tear film
what is the importance of doing fisher-schweizer's corneal patterns using fluorescein dye
determine aqueous leakage post intraocular operations
determine if there is epithelial breaks wherein the dye is located at anterior aqueous chamber
shows corneal dendritic pattern on cornea
shows fishnet mosaic pattern of pre corneal tear film
what is the importance of using fluorescein dye in herpetic keratitis
determine aqueous leakage post intraocular operations
determine if there is epithelial breaks wherein the dye is located at anterior aqueous chamber
shows corneal dendritic pattern on cornea
shows fishnet mosaic pattern of pre corneal tear film
most common living microbe contaminant of fluorescein dye
fusarium
escherichia coli
staphylococcus aureus
pseudomonas aeruginosa
what is present in fluress that will prevent overgrowth of most common living microbe contaminant of fluorescein dye
sodium borate
benoxinate
EDTA
BAK
filter used during slit lamp examination using fluorescein dye
cobalt blue
green filter
yellow light
red filter
MOA of fluorescein dye
pass and stain corneal epithelial breaks
stain mucus secretions
stain dead devitalized cells
AOTA
interpret if the result on TBUT using fluorescein dye is 7 seconds
pxs have dry eye syndrome
px have normal tear film
px have blockage at lacrimal passage
px have increase lacrimal secretion
interpret if the result on jones test showed heavily stained irrigant (NSS) with fluorescein dye
pxs have dry eye syndrome
px have normal tear film
px have blockage at lacrimal passage
px have increase lacrimal secretion
interpret if the result on schirmer's test with anesthesia combine with fluorescein dye is >30mm
pxs have dry eye syndrome
px have normal tear film
px have lacrimation
NOTA
local ester anesthesia is instilled initially before schirmer's test and applanation tonometry. what is the most common approved local ester anesthetic agent used by the optometrist
0.4% benoxinate
2% cocaine
0.5% proparacaine
2% lidocaine
0.5% proparacaine was instilled at 11am prior to pterygium excision. at what time will the ophthalmologist will instill another drop so that the the px will not feel the pain prior to sub conjunctival injection of another local anesthetic agent
11:30AM
11:20AM
11:45AM
after 5 minutes of instillation
propriety name of 0.5% proparacaine
mydriacyl
miostat
mydfrin
alcaine
classify 0.5% tropicamide
cholinomimetic agent
adrenomimetic agent
parasympatholyticagent
sympatholytic
agent
what are the ocular effects of 0.5% tropicamide during refraction
produce mydriasis with cycloplegia
produce mydriasis w/o cycloplegia
produce miosis with accommodation
produce miosis w/o accommodation
color cap of 0.5% tropicamide
red
green
brown
blue
classify 0.5% tropicamide according to its use
diagnostic agent
curative agent
palliative agent
protective
classify 2% pilocarpine
cholinomimetic agent
adrenomimetic agent
parasympatholytic agent
sympatholytic agent
why is it that pilocarpine is given immediately after instillation of tropicamide
it will reverse the mydriatic effect of tropicamide to widen the trabecular angle
it will reverse the mydriatic effect of tropicamide to narrow the trabecular angle
it will lower the IOP by decreasing the aqueous humor secretion
AOTA
color cap of 2% pilocarpine
red
green
brown
blue
classify 2% pilocarpine according to its use to prevent elevation of IOP
diagnostic agent
curative agent
palliative agent
protective agent
why is it that the px was subjected for cycloplegic refraction rather than using auto-refraction
px is not in right mental condition
px might not be educated to identify object
px is uncooperative during actual refraction
AOTA
main contraindication of using 0.5% tropicamide
primary angle close glaucoma
primary open angle glaucoma
mental disorder
cycloplegic refraction
how does 2% pilocarpine lower the IOP
open the trabecular by contraction of ciliary muscles
widen the trabecular angle by contraction of sphincter pupillae
enhance the outflow of the aqueous humor
AOTA
propriety name of 2% pilocarpine
mydriacyl
isopto carpine
mydfrin
alcaine
propriety name of 0.5% tropicamide
mydriacyl
isopto carpine
mydfrin
alcaine
time wherein pilocarpine will reverse the mydriatic effect of tropicamide if the tropicamide was instilled at 3pm
3:30pm
4:00pm
4:30pm
5:00pm
how long will be the miotic effect of pilocarpine after instillation
4 hours
2 hours
8 hours
24 hours
which is better to use in suspected angle closure glaucoma
2% pilocarpine
2% cyclopentolate
0.5% tropicamide
1% atropine
a 43 y/o female optometry student is reviewing for board examination. Every time that she started to review her notes, she manifested sudden ocular pain, seeing halos around light and blurring of vision. She consulted an ophthalmologist and was diagnosed with glaucoma. The ff. are the medication given to control the IOP: oral acetazolamide and Travaprost combine with timolol ophthalmic solution. What do you think is the type of glaucoma manifested by the px
primary angle closure glaucoma
primary open angle glaucoma
secondary angle closure glaucoma
secondary open angle glaucoma
which of the ff. procedures will NOT confirm the diagnosis of glaucoma
perimetry
tonometry
shadow test
biomicroscopy
what is the type of red eye manifested by the px with glaucoma
conjunctival injection
ciliary injection
subconjunctival hemorrhage
retinal hemorrhage
where does travaprost belong as anti-glaucoma agent
beta blocker
carbonic anhydrase inhibitor
prostaglandin analog
cholinomimetic agent
what the MOA of travaprost to lower IOP in glaucoma
decreasing the aqueous humor secretions
enhanced the uveoscleral outflow
enhancing the outflow directly opening the trabecular meshwork
enhancing outflow by ciliary muscles contraction (accommodation)
what is the color cap of ophthalmic travaprost
blue or yellow
green
orange
turquoise
classify travaprost according to its use
diagnostic agent
curative agent
palliative agent
protective agent
where does timolol belong as anti-glaucoma agent
beta blocker
carbonic anhydrase inhibitor
prostaglandin analog
cholinomimetic agent
what the MOA of timolol to lower IOP in glaucoma
decreasing the aqueous humor secretions
enhanced the uveoscleral outflow
enhancing the outflow directly opening the trabecular meshwork
enhancing the outflow by ciliary muscles contraction (accommodation)
what is the color cap of ophthalmic timolol
blue or yellow
green
orange
turquoise
classify timolol according to its use
diagnostic agent
curative agent
palliative agent
protective agent
where does acetazolamide belong as anti glaucoma agent
beta blocker
carbonic anhydrase inhibitor
prostaglandin analog
cholinomimetic agent
what the MOA of acetazolamide to lower IOP in glaucoma
decreasing the aqueous humor secretions
enhanced the uveoscleral outflow
enhancing the outflow directly opening the trabecular meshwork
enhancing the outflow by ciliary muscles contraction (accommodation)
if ophthalmic dorzolamide was given instead of acetazolamide, what is the color cap of dorzolamide
blue or yellow
green
orange
turquoise
classify dorzolamide according to its use
diagnostic agent
curative agent
palliative agent
protective agent
if pilocarpine was also given as anti glaucoma agent, where does it belong
beta blocker
carbonic anhydrase inhibitor
prostaglandin analog
cholinomimetic agent
how does pilocarpine lower IOP in glaucoma
decreasing the aqueous humor secretions
enhanced the uveoscleral outflow
enhancing the outflow directly opening the trabecular meshwork
enhancing the outflow by ciliary muscles contraction (accommodation)
what is the color cap of ophthalmic pilocarpine
blue or yellow
green
orange
turquoise
if the px hx reveals previous medical hx of iridocyclitis, what is the px type of glaucoma
primary angle closure glaucoma w/o pupillary block
primary open angle glaucoma
secondary angle closure glaucoma with pupillary block
secondary open angle glaucoma w/o pupillary block
if surgery warrant the treatment in px with iridocyclitis, what is the best surgical management to control the IOP
laser iridotomy
trabeculectomy
vitrectomy
laster assisted in situ keratomileusis
a 30 y/o male px seek for eye refraction. He was diagnosed with horner's syndrome. refraction revealed no EOR but on physical eye examination, there was pathologic conditions. which of the pathologic eye conditions is NOT typically present in Horner's syndrome
partial blepharoptosis
miosis
anhidrosis
esotropia of the OS
what causes ptosis in Horner's syndrome
injury on parasympathetic nerve innervating the dilator pupillae
weakness of the mueller's muscles of eyelids
injury on sympathetic nerve innervating the sphincter pupillae
weakness of the ciliary muscles
what is the initial ophthalmic medication (screening test) to test horner's syndrome
4% cocaine
1% hydroxyamphetamine
2.5% phenylephrine
1% epinephrine
if the initial test ophthalmic medication will not dilate the pupil in horner's syndrome, what is the next ophthalmic medication to confirm the diagnosis
4% cocaine
1% hydroxyamphetamine
2.5% phenylephrine
1% epinephrine
if the confirmatory medication that the eye doctor used will not dilate the pupil in Horner's syndrome, where is the probable lesion located
preganglionic sympathetic nerve
postganglionic sympathetic nerve
at the pretectal nucleus of midbrain
at edinger westphal nucleus of midbrain
which of the ff. eye drops will dilate the pupil in horner's syndrome since this px is hyperreactive to mydriatic agent
4% cocaine
1% hydroxyamphetamine
2.5% phenylephrine
0.1% epinephrine
classify cocaine used in Horner's syndrome
diagnostic agent
curative agent
palliative agent
protective agent
classify hydroxyamphetamine used in Horner's syndrome
diagnostic agent
curative agent
palliative agent
protective agent
which of the ff. is NOT the characteristic of fluorescein dye
smallest of ophthalmic dye with molecular weight of 376
stain devitalized cells and mucus
give yellow green color on cobalt blue filter
safely use in strip than in solution to prevent contamination
what intraocular dye introduced during phacoemulsification
lissamine green dye
fluorescein dye
indocyanine green dye
trypan blue dye
what is the use of introducing intraocular dye during phacoemulsification
to stain the cataractous crystalline lens
to stain the anterior lens capsule during capsulorrhexis
to stain the posterior lens capsule during capsulorrhexis
to stain site of incision at cornea if there is corneal leakage after phacoemulsification
why biometry is done prior to phacoemulsification
measure the power of the cornea and length of the eye
measure the power of the lens and the cornea
measure the power of the lens and length of the eye
measure the power of the lens & cornea plus length of the eye
if the IOL implants became opaque after 5 years it is implanted, what is the best method to remove the opacity after phacoemulsification with IOL implant
subject the px again for phacoemulsification and replaced the opaque IOL implant
subject the px for YAG laser to punch a hole on posterior opaque capsule
subject the px for photocoagulation
subject the px for LASIK or LASEK
which of the ff. characteristic of fluorescein dye that gives fishnet-like pattern of fluorescein in tear film after rubbing the eye instilled with fluorescein dye
seidel test
fisher-schweizer's corneal mosaic
quenching phenomenon
pseudoflare
which of the ff. characteristic of fluorescein dye wherein the fluorescence or luminosity losses as the concentration of fluorescein dye increases to >0.001%
seidel test
fisher-schweizer's corneal mosaic
quenching phenomenon
pseudoflare
which of the ff. characteristic of fluorescein dye wherein the fluorescence or luminosity losses as the pH of the dye increases to >8pH
seidel test
fisher-schweizer's corneal mosaic
quenching phenomenon
pseudoflare
which of the ff. characteristic of fluorescein dye appearing as greenish glow behind the cornea once the fluorescein dye is instilled on the cornea and penetrate whole corneal layers into the aqueous chamber due to corneal epithelial damage
seidel test
fisher-schweizer's corneal mosaic
quenching phenomenon
pseudoflare
which of the ff. characteristic of fluorescein dye once instilled on eye, the dye is seen flowing downward from surgical or penetrating wound on the cornea appearing as bright green in contrast to duller, yellow - orange background
seidel test
fisher-schweizer's corneal mosaic
quenching phenomenon
pseudoflare
which of the ff. is NOT the indication of using fluorescein dye using strip
TBUT
Jones test
RGP cl fitting
fluorescein angiography
ophthalmic dye which has NO strip preparation, given ONLY intravenous
lissamine green dye
indocyanin green dye
rose bengal dye
fluorescein dye
which of the ff. dye does NOT stain devitalized cells on cornea and conjunctiva
lissamine green dye
rose bengal dye
fluorescein dye
methylene blue
which of the ff. dye given IV will visualized both retinal and choroidal blood vessels clearly
lissamine green dye
indocyanin green dye
rose bengal dye
fluorescein dye
what is the anesthetic agent combine with fluorescein dye in Fluress
proparacaine
benoxinate
bupivacaine
lidocaine
where does the anesthetic agent benoxinate in fluress belong
amide local anesthetic
ester local anesthetic
general anesthetic
inhalation anesthetic
why is it that the anesthetic agent benoxinate in fluress is combine with fluorescein dye
to suppress the growth of pseudomonas aeruginosa
to suppress the growth of candida albicans
to suppress the growth of acanthamoeba
to suppress the growth of herpes keratitis
who is the common contaminant among homemade saline solution for eye wash
pseudomonas aeruginosa
staphylococcus aureus
candida albicans
acanthamoeba
what is the other use of benzalkonium chloride in the CL solution
wetting agent
excipient
ophthalmic vehicle
compartment
which of the ff. is NOT the uses of thimerosal CL solution
antiseptic agent for Staphylococcus aureus
antimycotic agent for fusarium
antiviral agent for herpes simplex
acting as preservative
what is the possible consequence to neonate on prolong use of thimerosal in ophthalmic solution during gestation
autism
congenital cataract
arrhythmia
COPD
what should be added to CL solution if it contains thimerosal as preservative to prevent deposition of calcium in the cornea
BAK
deferoxamine
EDTA
penicillamine
which of the ff. is NOT the component of the CL solution
BAK
EDTA
thimerosal
amoxicillin
which of the ff. is NOT a physiologic organic contaminant of CL
proteins
sodium
lipids
mucin
most common physiologic organic contaminant of CL
proteins
sodium
lipids
mucin
what is the characteristic of the CL if CL contaminant is proteins
slick and greasy
filmy and doughnut patterm
dendritic patterns
punctate opacity
what is the characteristic of the CL if CL contaminant is lipids
slick and greasy
filmy and doughnut patterm
dendritic patterns
punctate opacity
what is the characteristic of the CL if CL contaminant is mucin
slick and greasy
filmy and doughnut patterm
dendritic patterns
punctate opacity
what is the ocular side effect of thimerosal on prolong use
band keratopathy
optic neuritis
macular degeneration
papilledema
why is EDTA is added if the CL solution contains thimerosal
chelate the calcium
chelate the iron rust
chelate the copper deposits
chelate the gold deposits
which of the ff. protein enzyme, that remove protein deposits at the CL, comes from Bacillus lichenformis
papain
subtilisin
pancreatin
lipase
which of the ff. protein enzyme, that remove protein deposits at the CL, comes from papaya extract
papain
subtilisin
pancreatin
lipase
which of the ff. protein enzyme, that remove protein deposits at the CL, comes from pancreas extract
papain
subtilisin
pancreatin
lipase
most commonly abused OTC medication
acetaminophen
amoxicillin
mefenamic acid
ibuprofen
most commonly abused non - OTC antibiotic
ofloxacin
amoxicillin
tetracycline
cefuroxime
why is that there is disparity in the effect of the paracetamol since both of them are given the same dose and brand product
probably one of the px took heavy meal before taking the medication
probably one of the px has high grade fever while the other one has only mild fever
probably one of the px took only small amount of water as compared to the other
probably both of them are lactating which affect drug absorption
which among the ff. glands excrete the largest amount of paracetamol
kidneys
lacrimal glands
salivary glands
mammary glands
the ff. are the core aspects of pharmacokinetic of the paracetamol, which of the ff. does NOT belong to pharmacokinetics
biotransformation
bioavailability
pharmacologic effect
elimination
where does paracetamol belong
narcotic analgesic
NSAID
aspirin congener
NOTA
what is the enhancement of drug effect when epinephrine and pilocarpine was combined for treatment
additive
synergism
potentiation
antagonism
what is the receptor site being interacted upon by pilocarpine
nicotinic receptor
a1 receptor
a2 receptor
muscarinic 3 receptor
what is the ocular effect using pilocarpine
brucke's muscles contract thus opening the trabecular meshwork
conjunctival blood vessels constrict
pupils dilate
decrease aqueous humor secretion
what pharmacologic principle when pilocarpine combine with specific receptor site
"lock and key"
bell's phenomenon
crocodile tears
dalrymple sign
what is the specific receptor site if epinephrine will produce mydriasis
b1 receptor
a1 receptor
a2 receptor
muscarinic 3 receptor
what is the specific receptor site if epinephrine will produce conjunctival blanch
b1 receptor
a1 receptor
a2 receptor
muscarinic 3 receptor
what is the specific receptor site if epinephrine will directly open the trabecular meshwork
b1 receptor
a1 receptor
a2 receptor
muscarinic 3 receptor
what is the specific receptor site if epinephrine will decrease the aqueous humor secretions
b1 receptor
a1 receptor
a2 receptor
muscarinic 3 receptor
pertaining to drug selectivity, how would you classify epinephrine
highly selective
non selective
partly selective
no selectivity at all
what is meaning of one gutta
one ml
one drop
every one hour
every one day
if the resident MD instruct the px to instill the meds TID instead of once a day, what is the legal concept on the prescription order
doctrine of informed consent
doctrine of respondent superior
doctrine on minors and incompetent
doctrine on senior citizen
The resident MD properly instruct the px on how to instill the meds and what is it for. What is the legal concept on the prescription order
doctrine of informed consent
doctrine of respondent superior
doctrine on minors and incompetent
doctrine on senior citizen
